Publication of a study by Prof. Kopera et al.
The latest edition of the JDDG (JDDG;2008, 6: 287-291) finally included a publication of the one-side study by Prof. Kopera, the results of which had previously only been discussed in the yellow press, and we have been given insight into the study design .... more
It is remarkable today to see how studies are tailored to produce a particular result. If nothing is intended to come out of them, nothing does.
Our points of criticism are as follows:
1. The bibliography does not mention a single publication by a NETWORK member. Either Prof. Kopera and her team are not aware of these publications, or they deliberately ignored them. Readers can decide for themselves which of these two alternatives is the worse.
2. The goal of the treatment and the actual treatment employed do not concur. The study speaks of lipomas located in the lateral region of the trochanter. What was actually treated was adiposity of the hips and thighs.
3. The patients were not carefully examined as to whether or not the deposits of fat contained large amounts of connective tissue; however, this a highly important aspect, especially for treatment of this region, and should be a factor in patient selection.
4. The treatment interval was 3, 6 and 9 weeks. This differs substantially from the protocols issued by the NETWORK, which specify treatment at intervals of 8 weeks.
5. Only 10 ml of PPC was injected, with 20 injections of 0.5 ml each. All experience has shown that at least 30 ml must be injected on each side; in dilution, this means 60 ml, i.e. altogether 120 injections. We therefore assume that the unsatisfactory results were due above all to the dosage, which was much too low.
6. No information is given in the study design on the spacing of the injections. We are forced to suspect that the distance between the injections was far too great if indeed one-side hip and thigh treatment was carried out.
7. The authors themselves regret the shortage of literature and therefore the need to rely on their own experience in the therapy of lipomas. With knowledge of the articles published by our members, very much more precise protocols could have been produced – see point 1 of our criticism. Moreover, the NETWORK wrote to Prof. Kopera several times, offering to provide her with our tried-and-tested NETWORK protocols. However, we never received a reply.
Conclusion: Because of its deficient design, the study must, in our view, be regarded as worthless, it could not produce any other results than those that it did.
Dr. Franz Hasengschwandtner
Medical and Scientific Director
Trainings & Workshops:
(click on image)
+49 -2508-21 59-200
Please visit our
Congress Lectures by NETWORK Members
Canada: CACS 5th Annual Congress
Short information about the congress
October 24/25/26, 2008
Montefiore Club, 1195 Guy, Montreal, QUE
Topics: Esthetic medicine & surgery
Lipolysis - Lasers - Fillers
Botox - Fat transfer - Breast - Facelifts - etc.
NETWORK director Dr. Franz Hasengschwandt-
ner will present a lecture about IL - State of the Art.
Link to the programme
AAM & MEDISPA MIDDLE EAST
1st ICAAM & MEDISPA MIDDLE EAST
Intern. Congress in Aesthetic and Anti-aging Medicine & MediSpa
Dubai, UAE - Nov 29 to Dec 1, 2008
This Conference will discuss the latest cutting edge treatments for “Patient’s Global Management”, in the combination of aesthetic and anti-aging medicine.
NETWORK member Dr. Angelo-Khattar will give a lecture about Injection Lipolysis.
NETWORK members Dr. Ines Verner, (Israel) and Mark Palmer (UK) after their lectures on Peels and Injection Lipolysis at the "Interventional Cosmetics" Conference of The Royal Society of Medicine, London, Feb. 25th, 2008. Co-Founder of NETWORK-Lipolysis Ulrich Bunzek (GER) welcomed both at the NETWORK Information booth.